Time for Change? Has the Time Come for the Pharmaceutical Industry to Accept Modest Prices?
by Kate Dion
In this article, Kate Dion teams up with industry leaders to write a thought-provoking piece for ISPOR's Value and Outcomes Spotlight focused on potential pricing strategies pharma could explore for COVID-19 medicines.
Click here to read the article.
This article was originally featured on ISPOR's Value and Outcomes Spotlight on December 14, 2020.